Dr. Sandra Rieger of the MDI Biological Laboratory is studying the molecular mechanisms underlying peripheral neuropathy, a painful condition that causes pain, tingling and numbness in the hands and feet.
Sandra Rieger, Ph.D., conducts peripheral neuropathy research at MDI Biological Laboratory. A recent attendee of the Foundation for Peripheral Neuropathy 2016 International Research Symposium in Chicago, she recently wrote a post for the MDI Biological Laboratory’s blog, “Breaking Through,” that addresses in part her experiences at our symposium.
Peripheral neuropathy is usually associated with diabetes, but it’s also a common side effect of some chemotherapy drugs. Sandra Rieger, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, recently discovered where and how neuropathy begins when someone is on chemotherapy. It’s an important finding because ultimately it should lead to some effective treatments.
If you enjoy action movies, you can probably think of a superhero—maybe Wolverine?—who can lose a limb in battle, yet grow it right back and keep on going. But could regenerating a lost limb ever happen in real life? Some scientists are working hard to understand how other organisms do this.
Recent research by Sandra Rieger, Ph.D., of the MDI Biological Laboratory identifying the underlying mechanisms of peripheral neuropathy, or nerve damage, has raised the prospect that drug therapies can be developed for the treatment of this condition, which causes pain, numbness and/or tingling in the hands and feet.
The MDI Biological Laboratory and The Jackson Laboratory both will get federal funding to study nerve damage from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke.
An inspiring discovery that could save the lives of millions is being developed to reverse peripheral nerve damage.
The research of Sandra Rieger, Ph.D., on the molecular mechanisms underlying peripheral neuropathy was recently featured in a webinar on the science website, Science Mission.
A Mount Desert Island Biological Laboratory researcher has discovered two potential drugs that might be used to reverse peripheral nerve damage, a common side effect of chemotherapy.